# Refoxy Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/refoxy-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Cologne, Germany
- Website: www.refoxy.com/
- Total disclosed funding: $9.9M
- Latest round: Seed (Jul 31, 2024)
- Investors on record: 5

## About

Based in Cologne, Germany, and founded in 2020 by co-founder Dr. Victor Bustos (CEO) and Prof. Wolfgang Link, Refoxy Pharmaceuticals GmbH operates as a provider of therapeutics leveraging the FOXO3 transcription factor to address idiopathic pulmonary fibrosis and other fibrotic and cardiovascular conditions for healthcare systems in North America and Europe. In December 2024, Refoxy Pharmaceuticals GmbH raised EUR 9.1 million in seed funding led by Boehringer Ingelheim, with participation from Apollo Health Ventures, NRW.Venture, and High-Tech Grunderfonds.

Refoxy Pharmaceuticals specializes in discovering and developing advanced therapeutics aimed at the FOXO3 transcription factor. Their primary offerings include small molecule activators tailored to treat age-related conditions, including idiopathic pulmonary fibrosis (IPF) and various fibrotic and cardiovascular diseases. Utilizing their proprietary F.act finder platform, Refoxy conducts phenotypic screenings to identify effective FOXO3 activators, targeting primarily the North American and European markets, where such conditions are prevalent.

Refoxy Pharmaceuticals generates income through strategic partnerships with pharmaceutical companies, often structured around licensing agreements for its FOXO3 activators.

Refoxy aims to enter new markets in Asia by 2025, leveraging its recent funding to accelerate research and development initiatives that will broaden its therapeutic offerings and market reach.

## Funding rounds

- Seed, Jul 31, 2024, $9.9M — Boehringer Ingelheim Venture, High-Tech Gruenderfonds, Apollo Health Ventures, NRW.Venture, Infinitas Capital Group

## Investors

- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Apollo Health Ventures (https://capitalatlas.ai/funds/apollo-health-ventures) — Seed
- NRW.Venture (https://capitalatlas.ai/funds/nrw-venture) — Seed
- Infinitas Capital Group (https://capitalatlas.ai/funds/infinitas-capital-group) — Seed